16-56758527-T-A

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_014669.5(NUP93):​c.180-11T>A variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00107 in 1,596,650 control chromosomes in the GnomAD database, including 28 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0017 ( 7 hom., cov: 32)
Exomes 𝑓: 0.0010 ( 21 hom. )

Consequence

NUP93
NM_014669.5 splice_polypyrimidine_tract, intron

Scores

2
Splicing: ADA: 0.9148
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.132
Variant links:
Genes affected
NUP93 (HGNC:28958): (nucleoporin 93) The nuclear pore complex is a massive structure that extends across the nuclear envelope, forming a gateway that regulates the flow of macromolecules between the nucleus and the cytoplasm. Nucleoporins are the main components of the nuclear pore complex in eukaryotic cells. This gene encodes a nucleoporin protein that localizes both to the basket of the pore and to the nuclear entry of the central gated channel of the pore. The encoded protein is a target of caspase cysteine proteases that play a central role in programmed cell death by apoptosis. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 16-56758527-T-A is Benign according to our data. Variant chr16-56758527-T-A is described in ClinVar as [Benign]. Clinvar id is 1640265.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.00167 (255/152266) while in subpopulation EAS AF= 0.0424 (220/5184). AF 95% confidence interval is 0.0378. There are 7 homozygotes in gnomad4. There are 149 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 7 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
NUP93NM_014669.5 linkuse as main transcriptc.180-11T>A splice_polypyrimidine_tract_variant, intron_variant ENST00000308159.10 NP_055484.3
NUP93XM_005256263.4 linkuse as main transcriptc.180-11T>A splice_polypyrimidine_tract_variant, intron_variant XP_005256320.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
NUP93ENST00000308159.10 linkuse as main transcriptc.180-11T>A splice_polypyrimidine_tract_variant, intron_variant 1 NM_014669.5 ENSP00000310668 P1Q8N1F7-1

Frequencies

GnomAD3 genomes
AF:
0.00168
AC:
255
AN:
152148
Hom.:
7
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00124
Gnomad ASJ
AF:
0.000865
Gnomad EAS
AF:
0.0423
Gnomad SAS
AF:
0.000415
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00239
GnomAD3 exomes
AF:
0.00345
AC:
866
AN:
251278
Hom.:
20
AF XY:
0.00326
AC XY:
443
AN XY:
135828
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000232
Gnomad ASJ exome
AF:
0.000695
Gnomad EAS exome
AF:
0.0444
Gnomad SAS exome
AF:
0.000457
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000968
Gnomad OTH exome
AF:
0.00163
GnomAD4 exome
AF:
0.00101
AC:
1456
AN:
1444384
Hom.:
21
Cov.:
27
AF XY:
0.000967
AC XY:
696
AN XY:
719770
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000112
Gnomad4 ASJ exome
AF:
0.000461
Gnomad4 EAS exome
AF:
0.0300
Gnomad4 SAS exome
AF:
0.000512
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000301
Gnomad4 OTH exome
AF:
0.00289
GnomAD4 genome
AF:
0.00167
AC:
255
AN:
152266
Hom.:
7
Cov.:
32
AF XY:
0.00200
AC XY:
149
AN XY:
74434
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.00124
Gnomad4 ASJ
AF:
0.000865
Gnomad4 EAS
AF:
0.0424
Gnomad4 SAS
AF:
0.000416
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000735
Gnomad4 OTH
AF:
0.00237
Alfa
AF:
0.000641
Hom.:
0
Bravo
AF:
0.00193
Asia WGS
AF:
0.0160
AC:
55
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Nephrotic syndrome, type 12 Benign:1
Benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsFeb 10, 2022- -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 29, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
10
DANN
Benign
0.44
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.2

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.91
dbscSNV1_RF
Benign
0.53
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs138944474; hg19: chr16-56792439; API